Medicine Supply Notification · MSN/2024/041
Medicine Supply Notification: Cefalexin 125mg/5ml and 250mg/5ml oral suspension
MSN/2024/041 Tier 2 · medium · issued 10 Apr 2024
Presentations, as stated
Each product line re-expressed as the product named, the status the source stated and its expected-back phrase kept as written — not the source's sentence, and not an observation of stock. Roles are inferred from phrasing.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Cefalexin 125mg/5ml oral suspensionaffected product · inferred from phrasing | Out of stock, as stated | early-July 2024precision: early in the month · window end 10 Jul 2024, derived from “early-July 2024” | notice of 10 Apr 2024 |
| Cefalexin 250mg/5ml oral suspensionaffected product · inferred from phrasing | Out of stock, as stated | early-July 2024precision: early in the month · window end 10 Jul 2024, derived from “early-July 2024” | notice of 10 Apr 2024 |
| Cefalexin 250mg tabletsaffected product · inferred from phrasing | Out of stock, as stated | early-May 2024precision: early in the month · window end 10 May 2024, derived from “early-May 2024” | notice of 10 Apr 2024 |
| Cefalexin 250mg and 500mg capsulesnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 10 Apr 2024 |
| Cefalexin 500mg tabletsnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 10 Apr 2024 |
| Cefaclor (Distaclor®) 125mg/5ml and 250mg/5ml oral suspensionsnamed by the source as remaining available · inferred from phrasing | Stated as available; can support only a partial uplift | — not stated for this line | notice of 10 Apr 2024 |
| Cefuroxime (Zinnat®) 125mg/5ml oral suspensionnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 10 Apr 2024 |
| Alternative liquid formulations of antibioticsclass-level statement by the source, not a named product · inferred from phrasing | Stated as available | — not stated for this line | notice of 10 Apr 2024 |
What changed
- 10 Apr 2024Supply notification issuedsource post
- 10 Apr 2024Expected backsource post
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
post:1f6a65dd1a4c
- Recorded
- 23 Apr 2024 22:46 UTC (Internet Archive capture)the earliest capture we hold is the Internet Archive's, not first-hand
- Capture route
- Recovered from the Internet Archive — not first-hand capture
- Read from
- Community Pharmacy England post (DHSC notification as relayed)
- Captured at
- 23 Apr 2024 22:46 UTC
- Content hash
510a91ef254739f2d446b63b1cba2987e8619012ff85eb03e1c48b51f1055c2dsha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://cpe.org.uk/our-news/medicine-supply-notification-cefalexin-125mg-5ml-and-250mg-5ml-oral-suspension ↗
- Archive capture
- https://web.archive.org/web/20240423224646id_/https://cpe.org.uk/our-news/medicine-supply-notification-cefalexin-125mg-5ml-and-250mg-5ml-oral-suspension ↗
- Parser version
- 3
- Source anomalies
- multiple statuses on one line (['available_partial_uplift', 'available']) — recorded 'available_partial_uplift' (source line omitted; see the source document)
as recorded by the parser about the source as captured — flagged, never corrected
Dates are as stated in the source documents. Fuzzy source dates are kept fuzzy. Not an official NHS or DHSC service — in a shortage, follow the guidance issued to your pharmacy or prescriber.